ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Inflammation Disrupts Memory - What Can You Do to Protect Your Brain?

All About Ginkgo Biloba: Benefits of This Timeless Herbal Supplement

Yarrow Oil: Here's Why It Deserves a Place in Your First-Aid Kit

Trial Finds Reduction in Depressive Symptoms Following Magnesium Supplementation

Artificial sweeteners linked to risk of weight gain, heart disease and other health issues

Carnitine deficiency suggested as contributor to autism

Vitamin D supplement use associated with lower risk of breast cancer

Hop Oil: A Safe Sleep Aide

White Camphor Oil: The Purest Camphor Oil

Lutein — An Important Nutrient for Eye and Brain Health

 
Print Page
Email Article

Four Patients in Clinical Trial Ill after Medicating with Promising Alzheimer’s Vaccine

  [ 42 votes ]   [ Discuss This Article ]
www.ProHealth.com • January 28, 2002




The promising Alzheimer vaccine AN-1792, which showed impressive clinical results as a treatment for mild to moderate Alzheimer's disease last summer, has suffered a setback in the current Phase 2A clinical trial.

The Elan corporation and Wyeth-Ayerst Laboratories have decided to temporarily suspend dosing in this Phase 2A study after four patients in France were reported to have clinical signs consistent with inflammation in the central nervous system. All four patients are receiving appropriate medical care and the companies are working with clinical investigators to determine the cause of this development.

"The well-being of patients is always our paramount concern. Our decision to temporarily suspend further dosing, pending the results of our evaluation, is a standard approach to protect the safety of patients in clinical trials," stated Dr. Ivan Lieberburg, Elan's Chief Scientific and Medical Officer. "A decision will be made on resumption of dosing pending the outcome of this investigation."

There are many agents and mechanisms that can result in inflammation of the central nervous system, one being a viral infection. The presence of virus within the cerebrospinal fluid was reported in some of the four patients under investigation. However, the cause of the inflammation remains to be determined.

To date, approximately 360 patients have received multiple doses of AN-1792. In the Phase 2A study, 97 patients in France have received the drug.

The study is still ongoing however, and the dosing schedule should provide time for the clinical investigation to occur without jeopardizing study conduct.

In Phase 1 safety studies, AN-1792 was administered to more than 80 patients with mild to moderate Alzheimer's disease in a variety of dosage regimens. The results from the U.S. single dose trial, and the U.K. multiple dose trial indicated that AN-1792 was well tolerated and that a proportion of patients developed an appropriate immunological response to AN-1792.

The Phase 2A study was designed to measure the immune response to beta amyloid peptide immunization in patients with Alzheimer's disease. Patients with mild to moderate Alzheimer's disease were enrolled and evaluated using conventional cognitive tests and by other surrogate measures.

The results of this study are expected to provide additional information regarding the immune response to AN-1792, as well as valuable information useful for the development of other therapeutic agents being studied as part of the collaborative development program.



Post a Comment

Featured Products From the ProHealth Store
Vitamin D3 Extreme™ Mitochondria Ignite™ with NT Factor® Energy NADH™ 12.5mg


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function

Natural Remedies

Curcumin - a Golden Gift of Nature with Benefits Still Untold Curcumin - a Golden Gift of Nature with Benefits Still Untold
Are You Obtaining the Proper Enzymes? Are You Obtaining the Proper Enzymes?
When a Good Night's Sleep Is Just a Daydream... When a Good Night's Sleep Is Just a Daydream...
Optimize Your Immune System Naturally: Thymic Protein A Optimize Your Immune System Naturally: Thymic Protein A
Safely Burn Away Body Fat Safely Burn Away Body Fat

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map